January 23, 2018 / 11:50 AM / 6 months ago

BRIEF-Taiwan Leader Biotech gets TFDA approval for clinical trial of botanical drug LEAC-102 in Taiwan

Jan 23 (Reuters) - Taiwan Leader Biotech Corp :

* Says it gets TFDA approval for clinical trial of botanical drug LEAC-102 in Taiwan

* LEAC-102 is used for adjunctive therapy of colorectal cancer

* The clinical trial will start up in May

Source text in Chinese: goo.gl/1t63QG

Further company coverage: (Beijing Headline News)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below